1. Home
  2. FSUN vs AUPH Comparison

FSUN vs AUPH Comparison

Compare FSUN & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSUN
  • AUPH
  • Stock Information
  • Founded
  • FSUN 1892
  • AUPH 1993
  • Country
  • FSUN United States
  • AUPH Canada
  • Employees
  • FSUN 1176
  • AUPH N/A
  • Industry
  • FSUN Major Banks
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSUN Finance
  • AUPH Health Care
  • Exchange
  • FSUN Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • FSUN 955.6M
  • AUPH 1.0B
  • IPO Year
  • FSUN N/A
  • AUPH 1999
  • Fundamental
  • Price
  • FSUN $34.54
  • AUPH $7.21
  • Analyst Decision
  • FSUN Hold
  • AUPH Strong Buy
  • Analyst Count
  • FSUN 1
  • AUPH 3
  • Target Price
  • FSUN N/A
  • AUPH $10.33
  • AVG Volume (30 Days)
  • FSUN 25.1K
  • AUPH 798.9K
  • Earning Date
  • FSUN 01-01-0001
  • AUPH 11-07-2024
  • Dividend Yield
  • FSUN N/A
  • AUPH N/A
  • EPS Growth
  • FSUN N/A
  • AUPH N/A
  • EPS
  • FSUN 3.05
  • AUPH N/A
  • Revenue
  • FSUN $348,035,000.00
  • AUPH $207,105,000.00
  • Revenue This Year
  • FSUN N/A
  • AUPH $36.08
  • Revenue Next Year
  • FSUN $80.04
  • AUPH $19.41
  • P/E Ratio
  • FSUN $11.51
  • AUPH N/A
  • Revenue Growth
  • FSUN N/A
  • AUPH 29.35
  • 52 Week Low
  • FSUN $29.51
  • AUPH $4.71
  • 52 Week High
  • FSUN $43.80
  • AUPH $10.05
  • Technical
  • Relative Strength Index (RSI)
  • FSUN 5.07
  • AUPH 53.16
  • Support Level
  • FSUN $38.79
  • AUPH $6.85
  • Resistance Level
  • FSUN $40.33
  • AUPH $7.50
  • Average True Range (ATR)
  • FSUN 1.30
  • AUPH 0.21
  • MACD
  • FSUN -0.60
  • AUPH 0.00
  • Stochastic Oscillator
  • FSUN 0.98
  • AUPH 55.38

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company for Sunflower Bank, National Association. It provides a full range of deposit, lending, treasury management, wealth management and online banking products and services. The company operates in two segments - Banking operations and Mortgage operations, out of which the majority of the revenue is generated from the Banking operations segment.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: